CCL5 and rheumatoid arthritis: Additionally, mostly Nepalensinol B, and to a lesser extent, Miyabenol A, were able to downregulate chemokine ligand 5 (CCL5), which was found to be, among others, a pathogenic chemokine, being used for drug testing, both in human RA [88] and mouse chronic polyarthritis [89].